Pioglitazone hydrochloride

LUF5771 is a potent allosteric recombinant luteinizing hormone ( recLH ) and Org 43553 inhibitor. LUF5771 is able to partially activate the LH receptor with low efficacyIn VitroLUF5771 (1 µM or 10 µM) allosteric inhibition is

LUF5771 is a potent allosteric recombinant luteinizing hormone ( recLH ) and Org 43553 inhibitor. LUF5771 is able to partially activate the LH receptor with low efficacyIn VitroLUF5771 (1 µM or 10 µM) allosteric inhibition is

LUF5771 is a potent allosteric recombinant luteinizing hormone ( recLH ) and Org 43553 inhibitor. LUF5771 is able to partially activate the LH receptor with low efficacyIn VitroLUF5771 (1 µM or 10 µM) allosteric inhibition is

LUF5771 is a potent allosteric recombinant luteinizing hormone ( recLH ) and Org 43553 inhibitor. LUF5771 is able to partially activate the LH receptor with low efficacyIn VitroLUF5771 (1 µM or 10 µM) allosteric inhibition is

LY 303511 hydrochloride is a structural analogue of LY294002. LY303511 does not inhibit PI3K . LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells. LY303511 reversibly blocks K + currents (IC 50 =64.6±9.1 μM) in MIN6 insulinoma

Dynamin-related GTPase DRP1 partial inhibitor.

Dynamin-related GTPase DRP1 partial inhibitor.

Methyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide, also known as Piroxicam impurity G, is a benzothiazine derivative that has been found in Piroxicam formulations. Piroxicam is a non-steroidal anti-inflammatory compound that has been

mGluR2 antagonist 1 is a highly potent, orally bioavailable and selective class of mGluR2 negative allosteric modulator ( IC 50 of 9 nM) with excellent brain permeabilityIn VivoIn vivo, mGluR2 antagonist 1 (Compound 25) reverses the effect of mGluR2

InformationMI-136 MI-136 can specifically inhibit the menin-MLL interaction. It inhibits DHT-induced expression of androgen receptor (AR) target genes.TargetsMenin-MLL interactionIn vitroMI-136, a variant of a previously described inhibitor that can

InformationMI-136 MI-136 can specifically inhibit the menin-MLL interaction. It inhibits DHT-induced expression of androgen receptor (AR) target genes.TargetsMenin-MLL interactionIn vitroMI-136, a variant of a previously described inhibitor that can

InformationMI-136 MI-136 can specifically inhibit the menin-MLL interaction. It inhibits DHT-induced expression of androgen receptor (AR) target genes.TargetsMenin-MLL interactionIn vitroMI-136, a variant of a previously described inhibitor that can